218 related articles for article (PubMed ID: 37257390)
1. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G
Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
[TBL] [Abstract][Full Text] [Related]
6. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S
Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
Ciocchini M; Arbelbide J; Musso CG
Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
9. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathies of renal significance.
Gnanasampanthan S; Kousios A
Clin Med (Lond); 2023 May; 23(3):250-253. PubMed ID: 37236803
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
[TBL] [Abstract][Full Text] [Related]
12. How I treat monoclonal gammopathy of renal significance (MGRS).
Fermand JP; Bridoux F; Kyle RA; Kastritis E; Weiss BM; Cook MA; Drayson MT; Dispenzieri A; Leung N;
Blood; 2013 Nov; 122(22):3583-90. PubMed ID: 24108460
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
[TBL] [Abstract][Full Text] [Related]
14. Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi Syndrome and osteomalacia.
Gutiérrez-Peredo GB; Filho JCBO; Montaño-Castellón I; Gutiérrez-Peredo AJ; Crusoé EQ; Gusmao-Flores D
BMC Nephrol; 2022 Aug; 23(1):278. PubMed ID: 35945525
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment].
Smirnov AV; Afanasyev BV; Poddubnaya IV; Dobronravov VA; Khrabrova MS; Zakharova EV; Nikitin EA; Lysenko Kozlovskaya LV; Bobkova IN; Rameev VV; Batyushin MM; Moiseev IS; Darskaya EI; Pirogova OV; Mendeleeva LP; Biryukova LS
Ter Arkh; 2020 Sep; 92(7):10-22. PubMed ID: 33346441
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
17. Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.
Movilla Echeverri C; Montilla Cosano G; Rivera Garrido C; Suñer Poblet M; Suarez Benjumea A
Transplant Proc; 2023 Dec; 55(10):2301-2303. PubMed ID: 38030424
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Immunoglobulin Deposition Disease and Related Diseases.
Kanzaki G; Okabayashi Y; Nagahama K; Ohashi R; Tsuboi N; Yokoo T; Shimizu A
J Nippon Med Sch; 2019; 86(1):2-9. PubMed ID: 30918151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
